Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery
Launched by UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER ·
Trial Information
Current as of November 10, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at how community health workers can help African American children with Type 1 Diabetes better manage their condition using automated insulin delivery systems—devices that help control blood sugar more easily. The study focuses on children whose blood sugar control (measured by a test called HbA1c) is 8% or higher, which means their diabetes isn’t well controlled. Families will meet with a community health worker once a month for six months to get support and coaching on using their diabetes technology. After that, there will be six more months without extra help, but researchers will continue to monitor how the children’s devices are working.
To take part, children need to have Type 1 Diabetes, use an automated insulin delivery system, and have an HbA1c of 8% or above. The study will include both boys and girls. During the study, both the children and their parents or guardians will fill out simple questionnaires at the start and end of the six-month coaching period, and there will be an interview at the end to learn about their experience. This study aims to see if having community health workers as coaches can make managing diabetes easier and improve health outcomes for these children.
Gender
ALL
Eligibility criteria
About University Hospitals Cleveland Medical Center
University Hospitals Cleveland Medical Center is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with Case Western Reserve University, the center integrates cutting-edge medical education, comprehensive patient care, and pioneering clinical trials to enhance treatment options and improve patient outcomes. With a diverse range of specialized programs and a robust infrastructure for research, University Hospitals Cleveland Medical Center plays a vital role in translating scientific discoveries into effective therapies, ensuring access to the latest advancements in medicine for patients and communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Sarah A MacLeish, DO
Principal Investigator
University Hospitals Cleveland Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported